Filters close
Released: 2-Oct-2024 1:05 PM EDT
Inaugural Summit to Explore Artificial Intelligence
Endocrine Society

A new virtual conference will explore how artificial intelligence (AI) can help health care providers and scientists efficiently analyze vast amounts of data and make more informed decisions, the Endocrine Society announced today.

23-Sep-2024 9:00 AM EDT
Pregnant Women Who Sleep Less Than 7 Hours a Night May Have Children with Developmental Delays
Endocrine Society

Pregnant women who do not get enough sleep may be at higher risk of having children with neurodevelopmental delays, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

12-Sep-2024 9:00 AM EDT
Moderate Coffee and Caffeine Consumption Is Associated with Lower Risk of Developing Multiple Cardiometabolic Diseases, New Study Finds
Endocrine Society

Consuming moderate amounts of coffee and caffeine regularly may offer a protective effect against developing multiple cardiometabolic diseases, including type 2 diabetes, coronary heart disease and stroke, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

5-Sep-2024 9:00 AM EDT
Girls may start puberty early due to chemical exposure
Endocrine Society

Girls exposed to certain endocrine-disrupting chemicals (EDCs) may be more likely to start puberty early, according to new research published in Endocrinology, the flagship basic science journal of the Endocrine Society. EDCs mimic, block or interfere with hormones in the body's endocrine system.

3-Sep-2024 9:00 AM EDT
Pregnant women exposed to PFAS may be at risk for obesity, heart disease later in life
Endocrine Society

Women with higher levels of per- and polyfluoroalkyl substances (PFAS) during pregnancy may experience long-term weight gain and heart problems later in life, according to new research published in The Journal of Clinical Endocrinology & Metabolism.

Released: 21-Aug-2024 9:00 AM EDT
Endocrine Society honors endocrinology field’s leaders with 2025 Laureate Awards
Endocrine Society

The Endocrine Society today announced it has chosen 14 leading endocrinologists as winners of its prestigious 2025 Laureate Awards, the top honors in the field.

5-Aug-2024 9:00 AM EDT
Eating disorder risks elevated among women with PCOS
Endocrine Society

Women with the common reproductive and metabolic condition polycystic ovary syndrome (PCOS) face a greater risk of developing bulimia, binge eating disorder and disordered eating, according to new research published in The Journal of Clinical Endocrinology & Metabolism.

Released: 30-Jul-2024 9:30 AM EDT
Endocrine Society merges with program director organization APDEM
Endocrine Society

The Endocrine Society, the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions, announced it is merging with the Association of Program Directors in Endocrinology, Diabetes and Metabolism (APDEM).

Released: 22-Jul-2024 12:05 PM EDT
Endocrine Society representative to speak at Rep. DeLauro’s Hill event
Endocrine Society

The Endocrine Society’s Chief Policy Officer will be among the speakers at House Appropriations Committee Ranking Member Rosa DeLauro’s (CT-03) press conference to highlight the dangers of 2025 federal government funding proposals that would cut funding for biomedical research and public health.

Released: 11-Jun-2024 9:00 AM EDT
Endocrine Society urges passage of the Right to IVF Act
Endocrine Society

The Endocrine Society endorses the Right to IVF Act, which was introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA) and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF), and urges the Senate to pass the Right to IVF Act on June 12th to ensure that the freedom to start and grow a family is protected and accessible to everyone in the United States.

29-May-2024 9:00 AM EDT
Low socioeconomic status raises pregnant women’s risk of exposure to thyroid-disrupting chemicals
Endocrine Society

Exposure to some endocrine-disrupting chemicals (EDCs) that harm the thyroid gland has increased over the past 20 years among U.S. women of childbearing age and pregnant women, especially among those with lower social and economic status, a new study finds. The results will be presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

29-May-2024 9:00 AM EDT
Meditating with headband that tracks brain activity may improve surgical recovery in patients with Cushing’s
Endocrine Society

Patients with Cushing’s syndrome who are recovering from surgery and wear a headband that tracks brain activity while they meditate may have less pain and better physical functioning compared with patients not using the device, suggests a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

29-May-2024 9:00 AM EDT
Early menopause linked to greater risk for breast, and possibly ovarian cancer
Endocrine Society

Some women who experience menopause early—before age 40—have an increased risk for developing breast and ovarian cancer, according to research being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

29-May-2024 9:00 AM EDT
Type of weight loss surgery women undergo before pregnancy may influence children’s weight gain
Endocrine Society

The type of weight loss surgery women undergo before becoming pregnant may affect how much weight their children gain in the first three years of life, suggests a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

31-May-2024 9:00 AM EDT
Endocrine Society Guideline recommends healthy adults under the age of 75 take the recommended daily allowance of vitamin D
Endocrine Society

Healthy adults under the age of 75 are unlikely to benefit from taking more than the daily intake of vitamin D recommended by the Institutes of Medicine (IOM) and do not require testing for vitamin D levels, according to a new Clinical Practice Guideline issued today by the Endocrine Society.

29-May-2024 9:00 AM EDT
Telemedicine may increase endocrinology care access for under-resourced patients with diabetes and heart disease
Endocrine Society

Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according to a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

29-May-2024 9:00 AM EDT
Two medication classes reduced cardiovascular and liver events in people with type 2 diabetes
Endocrine Society

GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

29-May-2024 9:00 AM EDT
Metformin may be as safe as insulin during pregnancy, 11-year data shows
Endocrine Society

Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to research presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. This is the first study to look at longer term effects of metformin use during pregnancy.

29-May-2024 9:00 AM EDT
Stress from living in violent neighborhoods tied to aggressive lung cancer in Black men
Endocrine Society

Exposure to increased neighborhood violence has the power to change the glucocorticoid receptor (GR) for the stress hormone, cortisol, which may influence the aggressiveness of lung cancer, according to data presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

29-May-2024 9:00 AM EDT
Thyroid eye disease patients report maintained improvement 2 years after teprotumumab infusions
Endocrine Society

Most patients with thyroid eye disease treated with teprotumumab didn’t require additional treatments nearly 2 years later, according to industry-supported research being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass., and published in the journal Thyroid.



close
0.13991